Status:
COMPLETED
Cardiac Rehab Retrospective Review (CR3)
Lead Sponsor:
Medical University of Graz
Collaborating Sponsors:
Zoll Medical Corporation
Conditions:
Sudden Cardiac Death
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
All patients enrolled in the Austrian LifeVest Registry will be retrospectively screened for successfully completed ambulatory or stationary rehabilitation program. Baseline characteristics, complete ...
Eligibility Criteria
Inclusion
- Prescribed WCD as part of the Austrian WCD registry population from 2014-2018
- Partial (\>50%) or full completion of a rehabilitation program when wearing the WCD in Austria
- ≥18 years old and able to give informed consent
Exclusion
- \- none
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 12 2022
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04675957
Start Date
February 1 2021
End Date
April 12 2022
Last Update
April 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University
Graz, Austria, 8010